Colorectal cancer: from epidemiology to current treatment.
作者信息
Bendardaf Riyad
机构信息
Department of Oncology & Radiotherapy, Turku University Hospital, Savitehtaankatu 1, PB 52, FIN 20521, Turku, Finland.
出版信息
Libyan J Med. 2006 Jul 28;1(1):42-59. doi: 10.4176/060714.
Abstract
摘要
相似文献
1
Colorectal cancer: from epidemiology to current treatment.结直肠癌：从流行病学到当前治疗
Libyan J Med. 2006 Jul 28;1(1):42-59. doi: 10.4176/060714.
2
Epidemiology of colorectal cancer.结直肠癌的流行病学
Int J Mol Epidemiol Genet. 2016 Sep 30;7(3):105-114. eCollection 2016.
3
Overview of the epidemiology of colorectal cancer.结直肠癌流行病学概述。
Dis Colon Rectum. 1997 Apr;40(4):483-93. doi: 10.1007/BF02258397.
4
Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.炎症性肠病相关与非炎症性肠病相关结直肠癌的结局：监测流行病学和最终结果医疗保险研究。
Dis Colon Rectum. 2012 Mar;55(3):270-7. doi: 10.1097/DCR.0b013e318242620f.
5
Do nutraceutics play a role in the prevention and treatment of colorectal cancer?营养保健品在结直肠癌的预防和治疗中发挥作用吗？
Cancer Metastasis Rev. 2010 Sep;29(3):395-404. doi: 10.1007/s10555-010-9234-3.
6
Epidemiology of fecal mutagenicity.
Epidemiol Rev. 1986;8:92-105. doi: 10.1093/oxfordjournals.epirev.a036297.
7
The shifting epidemiology of colorectal cancer in sub-Saharan Africa.撒哈拉以南非洲地区结直肠癌的流行病学变化。
Lancet Gastroenterol Hepatol. 2017 May;2(5):377-383. doi: 10.1016/S2468-1253(16)30183-2. Epub 2017 Mar 18.
8
Colorectal cancer: update on recent advances and their impact on screening protocols.结直肠癌：近期进展及其对筛查方案影响的最新情况
J Natl Med Assoc. 2000 May;92(5):222-30.
9
Colorectal cancer: epidemiology, risk factors, and health services.结直肠癌：流行病学、危险因素与卫生服务
Clin Colon Rectal Surg. 2005 Aug;18(3):133-40. doi: 10.1055/s-2005-916274.
10
The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence.阿司匹林降低结直肠癌患者死亡率的效果：解读证据。
Cancer Treat Rev. 2017 Apr;55:120-127. doi: 10.1016/j.ctrv.2016.12.008. Epub 2017 Feb 20.
引用本文的文献
1
ROS/p38/p53/Puma signaling pathway is involved in emodin-induced apoptosis of human colorectal cancer cells.ROS/p38/p53/Puma信号通路参与大黄素诱导的人结肠癌细胞凋亡。
Int J Clin Exp Med. 2015 Sep 15;8(9):15413-22. eCollection 2015.
本文引用的文献
1
Cancer incidence and mortality in Europe, 2004.2004年欧洲的癌症发病率和死亡率
Ann Oncol. 2005 Mar;16(3):481-8. doi: 10.1093/annonc/mdi098. Epub 2005 Feb 17.
2
Preoperative versus postoperative chemoradiotherapy for rectal cancer.直肠癌术前与术后放化疗对比
N Engl J Med. 2004 Oct 21;351(17):1731-40. doi: 10.1056/NEJMoa040694.
3
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.西妥昔单抗单药治疗及西妥昔单抗联合伊立替康治疗伊立替康难治性转移性结直肠癌。
N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025.
4
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.直肠癌术前放疗后括约肌保留：一项比较短期放疗与常规分割放化疗的随机试验报告
Radiother Oncol. 2004 Jul;72(1):15-24. doi: 10.1016/j.radonc.2003.12.006.
5
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.奥沙利铂、氟尿嘧啶和亚叶酸作为结肠癌的辅助治疗。
N Engl J Med. 2004 Jun 3;350(23):2343-51. doi: 10.1056/NEJMoa032709.
6
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.贝伐单抗联合伊立替康、氟尿嘧啶和亚叶酸钙治疗转移性结直肠癌。
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
7
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.西妥昔单抗用于表达表皮生长因子受体的难治性结直肠癌患者的II期试验。
J Clin Oncol. 2004 Apr 1;22(7):1201-8. doi: 10.1200/JCO.2004.10.182. Epub 2004 Mar 1.
8
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.晚期结直肠癌中FOLFIRI序贯FOLFOX6或相反顺序：一项GERCOR随机研究
J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2.
9
Optimal use of the combination of irinotecan and 5-fluorouracil.
Semin Oncol. 2003 Jun;30(3 Suppl 6):68-77. doi: 10.1016/s0093-7754(03)00127-1.
10
Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.局部晚期直肠癌术前同步放化疗：高剂量放疗联合含奥沙利铂方案——里昂R0-04 II期试验
J Clin Oncol. 2003 Mar 15;21(6):1119-24. doi: 10.1200/JCO.2003.10.045.
Zotero 插件